The present invention relates to novel fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives having protein tyrosine kinase inhibitory activity, to a process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions, particularly cancer and other proliferative disorders.
本发明涉及具有
蛋白酪氨酸激酶抑制活性的新型
氟代取代的3,5-二
氰基-4-(1H-
吲哚-5-基)-2,6-二甲基-1,4-二氢
吡啶衍生物,以及其制备方法和用于治疗c-Met介导的疾病或c-Met介导的病况,特别是癌症和其他增生性疾病的用途。